Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...
A new study published in Alzheimer’s & Dementia highlights a significant step forward in diagnosing Dementia with Lewy Bodies ...
GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
GLP-1 users had a 12% lower risk of dementia and a reduced likelihood of psychosis and schizophrenia. “It’s hard to make a blanket recommendation, because the side effects are real," study ...